Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors
NCT ID: NCT04754529
Last Updated: 2025-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2021-11-11
2024-06-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
NCT00376818
Yoga in Treating Sleep Disturbance in Cancer Survivors
NCT00397930
Yoga Intervention in Head and Neck Cancer Patients Undergoing Concurrent Chemo-Radiation
NCT04146779
Yoga Program for Lung Cancer Patients and Caregivers
NCT02196844
Yoga Practice for Breast or Ovarian Cancer Patients
NCT02305498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To develop and test the feasibility of a standardized 12-week online hatha yoga intervention (n=30) of breathing and movement incorporating both restorative poses, breathing techniques, guided meditation.
SECONDARY OBJECTIVES:
I. To evaluate the yoga intervention in relation to self-reported levels of stress and quality of life in cancer survivors (n=30).
II. Feasibility of collecting blood and saliva at baseline and post-intervention for stress biomarkers, including cortisol and norepinephrine.
EXPLORATORY OBJECTIVE:
I. To determine how behavior change, quality of life (QoL), and biomarkers of adrenergic stress, inflammation, and immunosuppression are affected by a 12-week online yoga program completed by cancer survivors.
OUTLINE:
Patients receive online yoga intervention once a week (QW) for 12 weeks.
After completion of study, patients are followed up at 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supportive care (yoga)
Patients receive online yoga intervention QW for 12 weeks.
Quality-of-Life Assessment
Ancillary studies
Survey Administration
Ancillary studies
Yoga
Receive yoga intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality-of-Life Assessment
Ancillary studies
Survey Administration
Ancillary studies
Yoga
Receive yoga intervention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have been diagnosed with a cancer and have finished treatment
* Have been cleared for physical activity by a physician or nurse practitioner (physician or nurse practitioner name and date clearance received)
* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Exclusion Criteria
* Are pregnant or nursing
* Are unwilling or unable to follow protocol requirements
* Have skeletal instabilities and/or cardio-pulmonary comorbidities
* Have any condition which in the investigator's opinion deems the subject an unsuitable candidate to participate in this study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roswell Park Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathryn Glaser
Role: PRINCIPAL_INVESTIGATOR
Roswell Park Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Roswell Park Cancer Institute
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-00698
Identifier Type: REGISTRY
Identifier Source: secondary_id
I 891720
Identifier Type: OTHER
Identifier Source: secondary_id
I 891720
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.